Speaker illustration

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Member of:

European Society of Cardiology

Roxana Mehran, MD is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. As Director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally respected academic research center focused on developing randomized clinical trials, outcomes research projects and high impact academic publications. A prolific researcher, Dr. Mehran has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, and participates regularly in developing national clinical guidelines. She has authored more than 1000 peer-reviewed articles and is one of the most highly cited researchers in the field of cardiology. Dr. Mehran has founded numerous nationally and internationally recognized initiatives and organizations which have served to push the field of cardiology forward, improving the care of patients around the world.

Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session type: Symposium

Thumbnail

Trial Updates in ACS & PCI

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session type: Late-Breaking Science

Thumbnail

Hot Line - MASTER DAPT

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session type: Hot Line

Thumbnail

Congress committee e-posters choice in aortic and intervention

Event: ESC Congress 2021 - The Digital Experience

Topic: Diseases of the Aorta

Session type: Congress Committee e-posters Choice

Thumbnail

And then, there was only COVID-19, a transatlantic view on a common enemy.

Event: ACVC 2021

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Session type: Symposium

Thumbnail

Controversies in Antithrombotic Therapy: Is Triple Therapy Still Needed in Patients with Atrial Fibrillation Undergoing PCI?

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiovascular Pharmacotherapy

Session type: Debate Session

Thumbnail

Meet the Experts - Atrial fibrillation in patients with acute coronary syndromes: how annoying!

Event: ESC CONGRESS 2019

Topic: Acute Coronary Syndromes, Other

Session type: Focus with the Experts

Thumbnail

Cardiovascular risks of surgery and of TAVI

Event: ESC CONGRESS 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Moderated Posters

Thumbnail

Revascularisation strategies in ACS

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Moderated Posters

Thumbnail

Meet the trialist - ISAR-REACT 5

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

This platform is supported by

logo Novo Nordisk